Skip to content

Omeros OMER Gross Profit

Discontinued — last reported Q3 '21

Gross Profit at other companies

Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$21.81M+2.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.96B+9.8%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$52.17M+47.1%
Opko Health logo
Opko HealthOPK
$45.76M+7.4%
Eli Lilly logo
Eli LillyLLY
$16.22B+54.4%

Other financials

Income statement

See full
Revenue$9.9M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$765.73M+307%
P/S8.5×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

The official record: Omeros’s 10-Q, filed November 9, 2021, on SEC EDGAR. View the filing →

Ask your AI about Omeros's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's gross profit?
Omeros (OMER) reported gross profit of $29.67M in Q3 2021.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.